Search results
Cipla Q1 results preview: PAT may grow 6.5-14% YoY, up to 10% growth seen in revenue - The Economic...
The Economic Times· 2 hours agoCipla reported Q1FY25 net profit expected between Rs 1,061-1,135 crore, with YoY growth of 6.5%-14%....
Cipla To Sun Pharma: gRevlimid To Drive Q1 Sales Growth For Pharma, Say Analysts
NDTV Profit· 1 day agoHere's what brokerages expect for the pharma sector in first quarter of fiscal 2025.
Cipla Q1 Preview: Domestic business restructuring may moderate profit growth
CNBC Awaaz· 1 day agoDrugmaker Cipla Ltd is all set to release its results for the April-June quarter of FY25 on July 26....
Cipla Q1 Preview: Restructure in biz may dent sales; profits to rise 7%
Business Standard India· 1 day agoCipla is expected to see a decent June quarter with revenues estimated to increase in upper single...
Akums, India’s largest domestic-focused CDMO player, is all set to tap the capital market - ET...
The Economic Times· 11 hours agoFrom its modest start with a small manufacturing unit in 2004, the New Delhi-headquartered drug...
Q1 earnings this week: From HUL, Nestle India, Tech Mahindra to Cipla and Axis Bank, here are key...
Financial Express· 3 days agoCompanies like HUL, Bajaj Finance, Larsen & Toubro, Axis Bank, Nestle India, DLF, Canara Bank, Ashok...
US’ Biosecure Act targets China, seen to double India’s pharma contract manufacturing in 3 years
Financial Express· 7 days agoThe Indian pharmaceutical industry’s contract manufacturing business is likely to double over the...
Stock market update: Nifty Pharma index advances 0.94%
The Economic Times· 41 minutes agoThe Nifty Pharma index closed 0.94 per cent up at 21105.5.
RVNL, HAL: Is there more downside for Rail, Defense stocks post Budget?
Business Standard India· 1 day agoShares of rail and defense related companies bounced back in trades on Wednesday; however, charts...
Stock Alert: Here's why Bajaj Finance may underperform markets in near-term
Business Standard India· 1 day agoBajaj Finance share price target: Bajaj Finance, analysts said, may face net interest margin...